Symposium / Summit

Cambridge Healthtech Institute’s 9th Annual Immuno-Oncology Summit


Monday, October 4, 2021 - Wednesday, October 6, 2021


Westin Copley Place | Boston, MA & Online
Attendee at Cambridge Healthtech Institute’s 9th Annual Immuno-Oncology Summit

For almost a decade CHI's Immuno-Oncology Summit has been the leading annual conference providing the latest applied immuno-oncology research and supplying comprehensive and in-depth coverage across all modalities and stages in the pipeline. Each year, we assemble a melting pot of thought leaders from industry and academia to bring you the latest developments in immuno-oncology. The Summit provides access to a comprehensive three-day program and extensive networking opportunities.

Don't miss our 30-minute presentation taking place during the Preclinical and Translational Models track on Thursday, October 5th at 3 p.m.

Presentation Details:

Oliver Jonas Headshot

Implantable Microdevices: Changing the Game for In Vivo Pharmacology Studies

Oliver Jonas, PhD, Scientific Founder, Kibur Medical; and Assistant Professor in Radiology, Harvard Medical School

The implantable microdevice (IMD) is a translational tool that allows us to systematically screen many individual and combination therapies in a small cohort of study animals.

This session outlines how IMDs function, and how we use them to facilitate the collection of robust data for numerous applications including: 

  • Combination screening
  • Testing of compounds that have no PK or toxicology data
  • Candidate comparison
  • Specific biology, e.g., candidate interaction with TME
  • Clinical translation

Charles River is pleased to also contribute to the scientific program with the below poster. 

Where and What Off-target Assessments Using Tissue Cross-reactivity (TCR) and Retrogenix Cell Microarray Technologies | Nick Brown, Senior North American Business Development Manager, Retrogenix, a Charles River Company

Are you interested in meeting with one of our expert scientists? Complete the form to the right, and we’ll be in touch with scheduling options.